Nrc Health (NRC) Depreciation & Amortization (CF) (2010 - 2026)

Nrc Health has disclosed Depreciation & Amortization (CF) across 17 years of filings, most recently posting $2.2 million for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $2.2 million, up 40.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.3 million (up 34.89% YoY), and the FY2025 annual result was $7.6 million, up 26.6% from the prior year.
• Depreciation & Amortization (CF) came in at $2.2 million for Q1 2026 at Nrc Health, up from $2.1 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $2.2 million in Q3 2025 to a low of $1.3 million in Q2 2022.
• The 5-year median for Depreciation & Amortization (CF) is $1.5 million (2024), against an average of $1.6 million.
• Across the five-year window, Depreciation & Amortization (CF) sank 33.67% in 2022 and surged 41.98% in 2025, its largest moves.
• Nrc Health's Depreciation & Amortization (CF) stood at $1.4 million in 2022, then rose by 4.0% to $1.4 million in 2023, then climbed by 6.01% to $1.5 million in 2024, then soared by 41.49% to $2.1 million in 2025, then increased by 1.12% to $2.2 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $2.2 million (Q1 2026), $2.1 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.